References
- Cimo P. L., Moake J. L., Weigner R. S., BenMenachem Y., Khalil K. G. Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses. Amer. J. Hemat. 1979; 6: 125
- Blanke H., Leschke M., Strauer B. E. Heparin-induzierte Thrombopenie. Dtsch. Med. Wschr. 1987; 112: 96
- Silver D., Kapsch D. N., Tsoi E. K. M. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann. Surg. 1983; 198: 301
- Chong B. H., Pitney W. R., Castaldi P. A. Heparin induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that includes thromboxane synthesis and platelet aggregation. Lancet 1982; 1246: II
- King D. J., Kelton J. G. Heparin-associated thrombocytopenia. Ann. Intern. Med. 1984; 100: 535
- Kearsley J. H., Jeremy R. W., Coates A. S. Leucocytoclastic vasculitis and skin necrosis following subcutaneous heparin calcium. Anst. N. Z. J. Med. 1982; 12: 288
- White P. W., Sadd J. R., Nensel R. E. Thrombotic complications of heparin therapy. Including six cases of Heparin-induced skin necrosis. Ann. Surg. 1979; 190: 595
- Kelly R. A., Gelfaud J. A., Pincus S. H. Cutaneous necrosis caused by systemically administered heparin. J. Amer. med. Ass. 1981; 246: 1582
- Griffith G. C., Nichols G., Asher J. D., Flanagan B. Heparin osteoporosis. JAMA 1965; 193: 85
- Sachler J.-P., Lin L. Heparin-induced osteoporosis. B. J. Radiol. 1973; 46: 548
- Rupp W. M., McCarthy H. B., Rohde T. D., Blackshear P. J., Goldenberg F. J., Buchwald H. The risk of osteoporosis in patients treated with long-term intravenous heparin therapy. Curr. Surr. 1982; 39: 419
- Ringe J.-D., Becker K. Osteoporoseentwicklung bei Heparinlangzeittherapie. Med. Mo. Pharm. 1985; 8: 80
- Griffith H. T., Lin D. T. Y. Severe heparin osteoporosis in pregnancy. Postgrad. Med. J. 1984; 60: 424
- Bowman W. C. Textbook of Pharmacology. Blackwel Scientific Publications, Oxford
- Baskys B., Lever W. F. Lipases of blood and tissues. II. kinetic studies on heparin-induced plasmalipase. Arch. of Biochem. and Biophys. 1962; 99(1)31
- Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 1976; 72: 248
- Munson P. J., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding-systems. Analyt. Biochemistry 1980; 107: 220
- Tobler H. J., Engel G. Affiniy spectra: a novel way for the evaluation of equilibrium binding experiments. Naunyn-Schmiedeberg's Arch. Pharmacol. 1983; 322: 183
- Glossmann H., Lübbecke F. (125I)-HEAT: fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity. Naunyn-Schmiedeberg's Arch. Pharmacol. 1982; 321: 7
- U'Prichard D. C., Greenberg D. A., Snyder S. H. Binding characteristics of a radiolabelled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol. Pharmacol. 1977; 13: 454
- Hornung R., Presek P., Glossmann H. Alpha adrenoceptors in rat brain: direct identification with prazosin. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979; 308: 223
- Ruffolo R. R., Yaden E. L., Timmermans P. B. M. W. M., van Zwieten P. A., Hynes M. D. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine. J. Pharmacol. and Exp. Therap. 1984; 229(1)58
- Göthert M., Nolte J., Weinheimer G. Preferential blockade of postsyaptic alpha-adrenoceptors by BE 2254. Eur. J. Pharmacol. 1980; 70: 35
- Glossmann H., Lübbecke F., Bellemann P. (125I)-HEAT, a selective, high affinity, high specific activity ligand for alpha-1-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 318: 1
- Glossmann H., Presek P. Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl-nucleotides medulate agonist binding. Naunyn-Schmiedeberg's Arch. Pharmacol. 1979; 306: 67
- Greenberg D. A., U'Prichard D. C., Sheehan P., Snyder S. H. Alpha-Noradrenergic receptors in the brain: differential effects of sodium binding of (3H)-agonists and (3H)-antagonists. Brain Res. 1978; 140: 378